Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration

American Journal of Pathology

Volumn 185, Issue 3, 2015, Pages 847-861

  Ong, Sufey ^a   Ligons, Davinna L ^b   Barin, Jobert G ^b   Wu, Lei ^a   Talor, Monica V ^b   Diny, Nicola ^a   Fontes, Jillian A ^a   Gebremariam, Elizabeth ^b   Kass, David A ^b   Rose, Noel R ^a,b   Čiháková, Daniela ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD69 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR 1; GANGLIOSIDE GM1 ANTIBODY; GRANZYME B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PERFORIN; POLYCLONAL ANTIBODY; TRANSCRIPTION FACTOR GATA 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; CELL INFILTRATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME RELEASE; EOSINOPHIL; EOSINOPHILIC INFILTRATION; EXPERIMENTAL AUTOIMMUNE DISEASE; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; FLOW CYTOMETRY; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART PROTECTION; MALE; MOUSE; MYOCARDITIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; FIBROSIS; HEART MUSCLE; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

ANIMALS; APOPTOSIS; EOSINOPHILS; FIBROSIS; INFLAMMATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM;

EID: 84925070755     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.11.023     Document Type: Article

References (84)

1. L. Andreoletti, N. Leveque, C. Boulagnon, C. Brasselet, and P. Fornes Viral causes of human myocarditis Arch Cardiovasc Dis 102 2009 559 568
2. D. Cihakova, and N.R. Rose Pathogenesis of myocarditis and dilated cardiomyopathy Adv Immunol 99 2008 95 114
3. N.R. Rose, and D. Cihakova Cardiomyopathies Autoimmunity 37 2004 347 350
4. S. Seshadri, J. Narula, and P. Chopra Asymptomatic eosinophilic myocarditis: 2 + 2 = 4 or 5! Int J Cardiol 31 1991 348 349
5. B. Huston, V. Froloff, K. Mills, and M. McGee Death due to eosinophilic necrotizing myocarditis despite steroid treatment Am J Forensic Med Pathol 34 2013 95 97
6. U. Baandrup Eosinophilic myocarditis Herz 37 2012 849 852
7. A.M. Al Ali, L.P. Straatman, M.F. Allard, and A.P. Ignaszewski Eosinophilic myocarditis: case series and review of literature Can J Cardiol 22 2006 1233 1237
8. E. Carniel, G. Sinagra, R. Bussani, A. Di Lenarda, B. Pinamonti, G. Lardieri, and F. Silvestri Fatal myocarditis: morphologic and clinical features Ital Heart J 5 2004 702 706
9. L.T. Cooper, K.L. Baughman, A.M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G.N. Levine, J. Narula, R.C. Starling, J. Towbin, and R. Virmani The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology J Am Coll Cardiol 50 2007 1914 1931
10. A.K. Wensky, G.C. Furtado, M.C. Marcondes, S. Chen, D. Manfra, S.A. Lira, D. Zagzag, and J.J. Lafaille IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis J Immunol 174 2005 1416 1423
11. S. Al-Haddad, and R.H. Riddell The role of eosinophils in inflammatory bowel disease Gut 54 2005 1674 1675
12. A.B. Kay The role of eosinophils in the pathogenesis of asthma Trends Mol Med 11 2005 148 152
13. D. Fairweather, Z. Kaya, G.R. Shellam, C.M. Lawson, and N.R. Rose From infection to autoimmunity J Autoimmun 16 2001 175 186
14. E.K. Godeny, and C.J. Gauntt Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis J Immunol 137 1986 1695 1702
15. J. Loh, D.T. Chu, A.K. O'Guin, W.M. Yokoyama, and H.W. Virgin Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver J Virol 79 2005 661 667
16. S. Johansson, L. Berg, H. Hall, and P. Hoglund NK cells: elusive players in autoimmunity Trends Immunol 26 2005 613 618
17. R. Perricone, C. Perricone, C. De Carolis, and Y. Shoenfeld NK cells in autoimmunity: a two-edg'd weapon of the immune system Autoimmun Rev 7 2008 384 390
18. F. Santiago-Schwarz, C. Kay, C. Panagiotopoulos, and S.E. Carsons Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor J Rheumatol 19 1992 223 228
19. C. Pridgeon, G.P. Lennon, L. Pazmany, R.N. Thompson, S.E. Christmas, and R.J. Moots Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype Rheumatology (Oxford) 42 2003 870 878
20. N. Dalbeth, R. Gundle, R.J. Davies, Y.C. Lee, A.J. McMichael, and M.F. Callan CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation J Immunol 173 2004 6418 6426
21. J. Ren, Z. Feng, Z. Lv, X. Chen, and J. Li Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-alpha J Rheumatol 38 2011 2112 2118
22. N. Dalbeth, and M.F. Callan A subset of natural killer cells is greatly expanded within inflamed joints Arthritis Rheum 46 2002 1763 1772
23. F.D. Shi, K. Takeda, S. Akira, N. Sarvetnick, and H.G. Ljunggren IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells J Immunol 165 2000 3099 3104
24. Y.Z. Yang, P.Y. Jin, and Q.D. Wang [Natural killer cell activity and induction of alpha and gamma interferon in patients with Coxsackie B viral myocarditis] Chinese Zhonghua Xin Xue Guan Bing Za Zhi 16 1988 337 339 382
25. T. Kanda, S. Ohshima, K. Yuasa, T. Watanabe, T. Suzuki, and K. Murata Idiopathic myocarditis associated with T-cell subset changes and depressed natural killer activity Jpn Heart J 31 1990 741 744
26. L.H. Chow, Y. Ye, J. Linder, and B.M. McManus Phenotypic analysis of infiltrating cells in human myocarditis: an immunohistochemical study in paraffin-embedded tissue Arch Pathol Lab Med 113 1989 1357 1362
27. K. Takahashi, T. Aranami, M. Endoh, S. Miyake, and T. Yamamura The regulatory role of natural killer cells in multiple sclerosis Brain 127 2004 1917 1927
28. M. Afanasyeva, D. Georgakopoulos, and N.R. Rose Autoimmune myocarditis: cellular mediators of cardiac dysfunction Autoimmun Rev 3 2004 476 486
29. D. Cihakova, R.B. Sharma, D. Fairweather, M. Afanasyeva, and N.R. Rose Animal models for autoimmune myocarditis and autoimmune thyroiditis Methods Mol Med 102 2004 175 193
30. N. Neu, K.W. Beisel, M.D. Traystman, N.R. Rose, and S.W. Craig Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis J Immunol 138 1987 2488 2492
31. N.R. Rose The significance of autoimmunity in myocarditis Ernst Schering Res Found Workshop 55 2006 141 154
32. G.C. Baldeviano, J.G. Barin, M.V. Talor, S. Srinivasan, D. Bedja, D. Zheng, K. Gabrielson, Y. Iwakura, N.R. Rose, and D. Cihakova Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy Circ Res 106 2010 1646 1655
33. J.G. Barin, G.C. Baldeviano, M.V. Talor, L. Wu, S. Ong, F. Quader, P. Chen, D. Zheng, P. Caturegli, N.R. Rose, and D. Cihakova Macrophages participate in IL-17-mediated inflammation Eur J Immunol 42 2012 726 736
34. J.G. Barin, M.V. Talor, G.C. Baldeviano, M. Kimura, N.R. Rose, and D. Cihakova Mechanisms of IFNgamma regulation of autoimmune myocarditis Exp Mol Pathol 89 2010 83 91
35. D. Cihakova, J.G. Barin, M. Afanasyeva, M. Kimura, D. Fairweather, M. Berg, M.V. Talor, G.C. Baldeviano, S. Frisancho, K. Gabrielson, D. Bedja, and N.R. Rose Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation Am J Pathol 172 2008 1195 1208
36. M. Kasai, T. Yoneda, S. Habu, Y. Maruyama, K. Okumura, and T. Tokunaga In vivo effect of anti-asialo GM1 antibody on natural killer activity Nature 291 1981 334 335
37. S. Habu, H. Fukui, K. Shimamura, M. Kasai, Y. Nagai, K. Okumura, and N. Tamaoki In vivo effects of anti-asialo GM1, I: reduction of NK activity and enhancement of transplanted tumor growth in nude mice J Immunol 127 1981 34 38
38. T.D. O'Connell, M.C. Rodrigo, and P.C. Simpson Isolation and culture of adult mouse cardiac myocytes Methods Mol Biol 357 2007 271 296
39. A. Gonzalez, J.D. Katz, M.G. Mattei, H. Kikutani, C. Benoist, and D. Mathis Genetic control of diabetes progression Immunity 7 1997 873 883
40. L. Poirot, C. Benoist, and D. Mathis Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity Proc Natl Acad Sci U S A 101 2004 8102 8107
41. J.G. Barin, and D. Cihakova Control of inflammatory heart disease by CD4+ T cells Ann N Y Acad Sci 1285 2013 80 96
42. M.W. Johansson Activation states of blood eosinophils in asthma Clin Exp Allergy 44 2014 482 498
43. D. Voehringer, N. van Rooijen, and R.M. Locksley Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages J Leukoc Biol 81 2007 1434 1444
44. C. Yu, A.B. Cantor, H. Yang, C. Browne, R.A. Wells, Y. Fujiwara, and S.H. Orkin Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo J Exp Med 195 2002 1387 1395
45. L.L. Lanier Activating and inhibitory NK cell receptors Adv Exp Med Biol 452 1998 13 18
46. L.L. Lanier NK cell recognition Annu Rev Immunol 23 2005 225 274
47. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini Functions of natural killer cells Nat Immunol 9 2008 503 510
48. L. Wu, S. Ong, M.V. Talor, J.G. Barin, G.C. Baldeviano, D.A. Kass, D. Bedja, H. Zhang, A. Sheikh, J.A. Margolick, Y. Iwakura, N.R. Rose, and D. Cihakova Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy J Exp Med 211 2014 1449 1464
49. G. Xanthou, C.E. Duchesnes, T.J. Williams, and J.E. Pease CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 Eur J Immunol 33 2003 2241 2250
50. C. Barnig, M. Cernadas, S. Dutile, X. Liu, M.A. Perrella, S. Kazani, M.E. Wechsler, E. Israel, and B.D. Levy Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma Sci Transl Med 5 2013 174ra126
51. A. Awad, H. Yassine, M. Barrier, H. Vorng, P. Marquillies, A. Tsicopoulos, and C. Duez Natural killer cells induce eosinophil activation and apoptosis PLoS One 9 2014 e94492
52. C.M. Sungur, Y.J. Tang-Feldman, A.E. Zamora, M. Alvarez, C. Pomeroy, and W.J. Murphy Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses Blood 122 2013 1518 1521
53. B. Zhang, T. Yamamura, T. Kondo, M. Fujiwara, and T. Tabira Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells J Exp Med 186 1997 1677 1687
54. M.G. Lassen, J.R. Lukens, J.S. Dolina, M.G. Brown, and Y.S. Hahn Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state J Immunol 184 2010 2693 2701
55. J.W. Fathman, D. Bhattacharya, M.A. Inlay, J. Seita, H. Karsunky, and I.L. Weissman Identification of the earliest natural killer cell-committed progenitor in murine bone marrow Blood 118 2011 5439 5447
56. E.D. Abston, J.G. Barin, D. Cihakova, A. Bucek, M.J. Coronado, J.E. Brandt, D. Bedja, J.B. Kim, D. Georgakopoulos, K.L. Gabrielson, W. Mitzner, and D. Fairweather IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function Circ Heart Fail 5 2012 366 375
57. J.G. Barin, G.C. Baldeviano, M.V. Talor, L. Wu, S. Ong, D. Fairweather, D. Bedja, N.R. Stickel, J.A. Fontes, A.B. Cardamone, D. Zheng, K.L. Gabrielson, N.R. Rose, and D. Cihakova Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A J Immunol 191 2013 4038 4047
58. M. Hyogo, T. Kamitani, A. Oguni, S. Kawasaki, H. Miyanaga, T. Takahashi, H. Kunishige, and H. Andachi Acute necrotizing eosinophilic myocarditis with giant cell infiltration after remission of idiopathic thrombocytopenic purpura Intern Med 36 1997 894 897
59. S.H. Litovsky, A.P. Burke, and R. Virmani Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells Mod Pathol 9 1996 1126 1134
60. H. Rezaizadeh, M. Sanchez-Ross, E. Kaluski, M. Klapholz, B. Haider, and C. Gerula Acute eosinophilic myocarditis: diagnosis and treatment Acute Card Care 12 2010 31 36
61. P.F. Weller, and G.J. Bubley The idiopathic hypereosinophilic syndrome Blood 83 1994 2759 2779
62. J.E. Heredia, L. Mukundan, F.M. Chen, A.A. Mueller, R.C. Deo, R.M. Locksley, T.A. Rando, and A. Chawla Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration Cell 153 2013 376 388
63. W.E. Louch, K.A. Sheehan, and B.M. Wolska Methods in cardiomyocyte isolation, culture, and gene transfer J Mol Cell Cardiol 51 2011 288 298
64. Y.C. Lim, and F.W. Luscinskas Isolation and culture of murine heart and lung endothelial cells for in vitro model systems Methods Mol Biol 341 2006 141 154
65. M. Afanasyeva, D. Georgakopoulos, D.F. Belardi, A.C. Ramsundar, J.G. Barin, D.A. Kass, and N.R. Rose Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function Am J Pathol 164 2004 807 815
66. J.G. Barin, N.R. Rose, and D. Cihakova Macrophage diversity in cardiac inflammation: a review Immunobiology 217 2012 468 475
67. N. Nielsen, V. Pascal, A.E. Fasth, Y. Sundstrom, E.D. Galsgaard, D. Ahern, M. Andersen, B. Baslund, E.M. Bartels, H. Bliddal, M. Feldmann, V. Malmstrom, L. Berg, P. Spee, and K. Soderstrom Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine NK degranulation towards RA synovial fibroblasts Immunology 142 2014 581 593
68. M. Balsamo, F. Scordamaglia, G. Pietra, C. Manzini, C. Cantoni, M. Boitano, P. Queirolo, W. Vermi, F. Facchetti, A. Moretta, L. Moretta, M.C. Mingari, and M. Vitale Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity Proc Natl Acad Sci U S A 106 2009 20847 20852
69. F.D. Shi, H.B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H.G. Ljunggren Natural killer cells determine the outcome of B cell-mediated autoimmunity Nat Immunol 1 2000 245 251
70. K. Fujiu, and R. Nagai Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development Basic Res Cardiol 108 2013 357
71. J. Zhang, Y. Wu, Z. Weng, T. Zhou, T. Feng, and Y. Lin Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway Brain Res 1582 2014 176 186
72. J.Y. Wang, S.D. Shyur, W.H. Wang, Y.H. Liou, C.G. Lin, Y.J. Wu, and L.S. Wu The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population Allergy 64 2009 1056 1060
73. R. Jin, S. Guo, L. Wu, X. Fan, H. Ma, D.B. Lowrie, and J. Zhang Il17A autoantibody induced by recombinant protein Ag85A-Il17A Appl Biochem Biotechnol 169 2013 502 510
74. X. Wu, Z. Zeng, L. Xu, J. Yu, Q. Cao, M. Chen, J.J. Sung, and P. Hu Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis Tumour Biol 35 2014 5347 5356
75. A. Mantovani The chemokine system: redundancy for robust outputs Immunol Today 20 1999 254 257
76. N.W. Lukacs, S.H. Oliveira, and C.M. Hogaboam Chemokines and asthma: redundancy of function or a coordinated effort? J Clin Invest 104 1999 995 999
77. T. Fujisawa, S. Velichko, P. Thai, L.Y. Hung, F. Huang, and R. Wu Regulation of airway MUC5AC expression by IL-1beta and IL-17A: the NF-kappaB paradigm J Immunol 183 2009 6236 6243
78. X.Q. Chen, Y.C. Yu, H.H. Deng, J.Z. Sun, Z. Dai, Y.W. Wu, and M. Yang Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity J Clin Immunol 30 2010 221 225
79. T. Fujisawa, M.M. Chang, S. Velichko, P. Thai, L.Y. Hung, F. Huang, N. Phuong, Y. Chen, and R. Wu NF-kappaB mediates IL-1beta- and IL-17A-induced MUC5B expression in airway epithelial cells Am J Respir Cell Mol Biol 45 2011 246 252
80. N. Zhao, J. Hao, Y. Ni, W. Luo, R. Liang, G. Cao, Y. Zhao, P. Wang, L. Zhao, Z. Tian, R. Flavell, Z. Hong, J. Han, Z. Yao, Z. Wu, and Z. Yin Vgamma4 gammadelta T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis J Immunol 187 2011 5007 5014
81. Q. Kong, Y. Xue, W. Wu, F. Yang, Y. Liu, M. Gao, W. Lai, and X. Pan IL-22 exacerbates the severity of CVB3-induced acute viral myocarditis in IL-17A-deficient mice Mol Med Rep 7 2013 1329 1335
82. H.G. Ljunggren, and K.J. Malmberg Prospects for the use of NK cells in immunotherapy of human cancer Nat Rev Immunol 7 2007 329 339
83. S.K. Lee, and S. Gasser The role of natural killer cells in cancer therapy Front Biosci (Elite Ed) 2 2010 380 391
84. E. Vivier, S. Ugolini, D. Blaise, C. Chabannon, and L. Brossay Targeting natural killer cells natural killer T cells in cancer Nat Rev Immunol 12 2012 239 252